Trial intelligence / Profile preview

SoSTART: Anticoagulation after Intracranial Haemorrhage

NCT03153150Phase 3Completed

Sponsor
University of Edinburgh
Start
Mar 2018
Primary completion
Mar 2021
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in Atrial fibrillation (AFib) (2 arms), sponsored by University of Edinburgh. Primary endpoints: The number of participants recruited per site per month at 1 year and Recurrent symptomatic spontaneous intracranial haemorrhage at 1 year. Started Mar 2018; status: completed.

02

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT03153150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03153150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call